{
  "id": 20923337,
  "title": "A GPNMB-associated lysosomal program tracks neurodegeneration across the DAM continuum",
  "url": "https://urgent.news/2026/11/20/a-gpnmb-associated-lysosomal-program-tracks-neurodegeneration-across",
  "topic": "science",
  "section": "Science",
  "published": "2026-11-20T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.11.20.767890v1?rss=1"
  },
  "original_language": "en",
  "account": "Frontotemporal dementia (FTD) and Alzheimer's disease (AD) cause major changes in the state of microglial cells. However, the relationship between the diversity of disease-associated microglia (DAM) and neurodegeneration is not fully understood. A study using a mouse model that mimics frontotemporal lobar degeneration (FTLD), including lysosomal issues, shows that blocking CSF1R can lower microgliosis but speed up neurodegeneration, indicating a protective effect of microglia under lysosomal stress. Single-cell analysis reveals that more Gpnmb expression in DAM shifts the cellular program from immune and inflammatory processes to a lysosomal, autolysosomal, and lipid-catabolic pathway. This GPNMB-associated program, which is dependent on TREM2, correlates with neurodegeneration across various disease models. Interestingly, Aβ-driven models with less neurodegeneration show more DAM activation but less GPNMB expression and engagement in this program. The GPNMB-associated program is influenced by TREM2 signaling, which, when impaired under lysosomal stress, leads to worse neuronal damage. Conversely, restoring lysosomal function reduces the GPNMB-associated program, showing that it is reversible. The presence of a similar lysosomal and microglial signature in CSF samples across different models aligns with alterations observed in human FTD. Overall, GPNMB marks a reversible, TREM2-regulated lysosomal transcriptional adaptation in DAM that changes in proportion to lysosomal stress and severity of neurodegeneration, suggesting a potentially protective role of microglia under such conditions.",
  "summary": "Frontotemporal dementia (FTD) and Alzheimer's disease (AD) profoundly remodel microglial states, yet how the heterogeneity of disease-associated microglia (DAM) relates to neurodegeneration remains incompletely understood. Using a progranulin (PGRN) and TMEM106B-deficient mouse model recapitulating key features of frontotemporal lobar degeneration (FTLD), including lysosomal impairment, we…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}